SYNLAB International GmbH has acquired Yhtyneet Medix Laboratoriot Oy

Target Company Name:
Country:
Advisory:
Sector:
Partner:

Yhtyneet Medix Laboratoriot Oy
Finland
Advisor to the seller
Healthcare & Pharmaceuticals
Aventum Partners

SYNLAB acquires 100 % of the shares in Yhtyneet Medix Laboratoriot Oy. Aventum acted as advisor to Aho Group and Minerva Foundation and other selling shareholders of YML.

Acquisition of leading Finnish laboratory services provider

Advisor to the seller :
Aventum Partners

Experts who worked on this transaction

Olli Klemola

Managing Partner at Aventum Partners

Riikka Makinen

Director at Aventum Partners

Joona Kalliokoski

Associate Director at Aventum Partners

Relevant transactions

Transactions

Cardioline acquired by ArchiMed

Advisor to the seller :
Brown Gibbons Lang & Company

Fenix Partners acted as sole financial advisor to the seller

Advisor to the seller :
Fenix Partners

DeRoyal Estonia OÜ

Financial Advisor to DeRoyal Estonia, part of the DeRoyal group, on the restructuring of the company.

Advisor :
Prudentia

EA Pharma has acquired a majority stake of the capital of the Spanish food supplements company Drasanvi.

Advisor to the seller :
Anquor Corporate Finance